The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Benzodiazepines: a summary of pharmacokinetic properties.
Open accessAbstract
1 The onset and duration of action of benzodiazepines after single oral doses depend largely on absorption rate and extent of distribution, respectively. 2 The rate and extent of accumulation during multiple dosage depend on elimination half‐life and clearance. A framework is proposed for classification of benzodiazepines according to elimination half‐life. 3 Long‐acting benzodiazepines have half‐life values usually exceeding 24 hours. Drugs in this category have long‐acting pharmacologically active metabolites (often desmethyldiazepam), accumulate extensively during multiple dosage, and may have impaired clearance in the elderly and those with liver disease. 4 Intermediate and short‐acting benzodiazepines have half‐life values from 5‐24 hours. Active metabolites are uncommon. Accumulation during multiple dosage is less extensive than with the long‐acting group, and diminishes as the half‐life becomes shorter. Age and liver disease have a small influence on metabolic clearance. 5 The half‐life of ultrashort acting benzodiazepines is less than 5 hours. These drugs are essentially non‐ accumulating. 6 Pharmacokinetic classification may assist in understanding of differences among benzodiazepines, but does not explain all of their clinical actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans
Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680119 · Cited by 197
Self-citationClobazam: pharmacological and therapeutic profile
Hanks, G. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04685.x · Cited by 32
Cited by
Anxiety and alcohol use disorders: comorbidity and treatment considerations
Smith, J. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.06 · Cited by 255
The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis
Crowe, S. F., & Stranks, E. K. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx120 · Cited by 209
Benzodiazepine Dependence: Avoidance and Withdrawal
Marriott, S., & Tyrer, P. (1993) · Drug Safety · doi:10.2165/00002018-199309020-00003 · Cited by 73
Furugen, A., Nishimura, A., Kobayashi, M., Umazume, T., Narumi, K., & Iseki, K. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.02.011 · Cited by 43
Metadata
- Authors
- Greenblatt, D., Shader, R., Divoll, M., & Harmatz, J.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1981-02
- Volume
- 11
- Issue
- S1
- Pages
- 11S-16S
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1610957450
- Cited by
- 190
- References
- 2
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines: a summary of pharmacokinetic properties. https://app.cochat.ai/papers/10.1111/j.1365-2125.1981.tb01833.x
- The paper
- Greenblatt, D., Shader, R., Divoll, M., & Harmatz, J. (1981). Benzodiazepines: a summary of pharmacokinetic properties. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1981.tb01833.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.